Quantinno Capital Management LP Acquires 502,024 Shares of Kenvue Inc. $KVUE

Quantinno Capital Management LP raised its holdings in Kenvue Inc. (NYSE:KVUE) by 59.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,345,956 shares of the company’s stock after purchasing an additional 502,024 shares during the period. Quantinno Capital Management LP owned 0.07% of Kenvue worth $23,204,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of KVUE. Physician Wealth Advisors Inc. boosted its holdings in Kenvue by 67.5% in the 4th quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company’s stock worth $26,000 after buying an additional 618 shares during the period. Elyxium Wealth LLC bought a new position in shares of Kenvue in the fourth quarter worth $26,000. MV Capital Management Inc. purchased a new position in shares of Kenvue in the fourth quarter valued at $28,000. Reflection Asset Management purchased a new position in shares of Kenvue in the fourth quarter valued at $32,000. Finally, SBI Securities Co. Ltd. raised its stake in shares of Kenvue by 82.4% during the 4th quarter. SBI Securities Co. Ltd. now owns 2,273 shares of the company’s stock valued at $39,000 after purchasing an additional 1,027 shares during the period. Institutional investors own 97.64% of the company’s stock.

Insider Activity at Kenvue

In other news, General Counsel Matthew Orlando sold 38,491 shares of the business’s stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $17.66, for a total transaction of $679,751.06. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.59% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. UBS Group increased their price objective on Kenvue from $18.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, July 16th. Barclays lifted their target price on Kenvue from $18.00 to $19.00 and gave the company an “equal weight” rating in a report on Tuesday, July 21st. Citigroup lowered their price target on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Wall Street Zen raised shares of Kenvue to a “buy” rating in a report on Sunday, July 12th. Finally, Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, July 7th. Three analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $19.58.

Kenvue Trading Down 0.3%

Shares of KVUE stock opened at $19.25 on Friday. The company has a market capitalization of $36.95 billion, a PE ratio of 22.64, a price-to-earnings-growth ratio of 1.46 and a beta of 0.47. Kenvue Inc. has a 52-week low of $14.02 and a 52-week high of $22.28. The business’s fifty day moving average is $18.59 and its 200 day moving average is $18.01. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98.

Kenvue (NYSE:KVUE) last posted its earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The firm’s revenue was up 4.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.24 earnings per share. On average, equities research analysts anticipate that Kenvue Inc. will post 1.16 EPS for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 26th. Stockholders of record on Wednesday, August 12th will be given a dividend of $0.21 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date is Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 4.4%. Kenvue’s dividend payout ratio is 98.82%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.